首页> 外文期刊>PLoS One >Antidepressive effect of an inward rectifier K + channel blocker peptide, tertiapin-RQ
【24h】

Antidepressive effect of an inward rectifier K + channel blocker peptide, tertiapin-RQ

机译:向内整流k +通道阻断肽,Tertiapin-rq的抗抗衰性作用

获取原文
           

摘要

Renal outer medullary K + channel, ROMK (Kir1.1, kcnj1) is expressed in the kidney and brain, but its role in the central nervous system remains unknown. Recent studies suggested an involvement of the ROMK channel in mental diseases. Tertiapin (TPN) is a European honey bee venom peptide and is reported to selectively block the ROMK channel. Here, we have chemically synthesized a series of mutated TPN peptides, including TPN-I8R and -M13Q (TPN-RQ), reported previously, and examined their blocking activity on the ROMK channel. Among 71 peptides tested, TPN-RQ was found to block the ROMK channel most effectively. Whole-cell patch-clamp recordings showed the essential roles of two disulfide bonds and the circular structure for the blockade activity. To examine the central role, we injected TPN-RQ intracerebroventricularly and examined the effects on depression- and anxiety-like behaviors in mice. TPN-RQ showed an antidepressive effect in tail-suspension and forced swim tests. The injection of TPN-RQ also enhanced the anxiety-like behavior in the elevated plus-maze and light/dark box tests and impaired spontaneous motor activities in balance beam and wheel running tests. Administration of TPM-RQ suppressed the anti-c-Fos immunoreactivity in the lateral septum, without affecting immunoreactivity in antidepressant-related nuclei, e.g. the dorsal raphe nucleus and locus coeruleus. TPN-RQ may exert its antidepressive effects through a different mechanism from current drugs.
机译:肾外外髓质k +通道,romk(kir1.1,kcnj1)在肾脏和大脑中表达,但其在中枢神经系统中的作用仍然未知。最近的研究表明罗姆克渠道参与精神疾病。 Tertiapin(TPN)是欧洲蜂蜜蜜蜂毒肽,并据报道选择性地阻止romk通道。这里,我们先前报道了一系列突变的TPN肽,包括TPN-I8R和-M13Q(TPN-RQ),并在romk信道上检查了它们的阻塞活动。在测试的71个肽中,发现TPN-RQ最有效地阻止romk信道。全细胞贴片夹具录制显示了两种二硫键的基本作用和阻断活动的圆形结构。为了检查中心作用,我们注射了TPN-RQ incracterriculary并检查了对小鼠的抑郁和焦虑的行为的影响。 TPN-RQ在尾部悬架和强制游泳测试中显示出抗抑郁作用。 TPN-RQ的注射还增强了升高的加迷宫和光/暗盒测试中的焦虑性行为,并且在平衡梁和车轮运行测试中受损的自发电动机活动。 TPM-RQ的施用抑制了侧面隔膜中的抗C-FOS免疫反应性,而不会影响抗抑郁相关核中的免疫反应性,例如,背部拉皮核和基因座菌。 TPN-RQ可以通过来自目前药物的不同机制发挥其抗抑制作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号